412 related articles for article (PubMed ID: 26645414)
21. Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure.
Zhao D; Zhou Y; Jiang C; Zhao Z; He F; Ran P
Respirology; 2018 Feb; 23(2):198-205. PubMed ID: 28906034
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Ekberg-Jansson A; Andersson B; Bake B; Boijsen M; Enanden I; Rosengren A; Skoogh BE; Tylén U; Venge P; Löfdahl CG
Respir Med; 2001 May; 95(5):363-73. PubMed ID: 11392577
[TBL] [Abstract][Full Text] [Related]
23. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD.
Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626
[TBL] [Abstract][Full Text] [Related]
24. Increased chemokines levels in patients with chronic obstructive pulmonary disease: correlation with quantitative computed tomography metrics.
Hao W; Li M; Pang Y; Du W; Huang X
Br J Radiol; 2021 Feb; 94(1118):20201030. PubMed ID: 33237823
[TBL] [Abstract][Full Text] [Related]
25. Airway dimensions in COPD: relationships with clinical variables.
Mair G; Maclay J; Miller JJ; McAllister D; Connell M; Murchison JT; MacNee W
Respir Med; 2010 Nov; 104(11):1683-90. PubMed ID: 20541384
[TBL] [Abstract][Full Text] [Related]
26. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
[TBL] [Abstract][Full Text] [Related]
27. Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD.
Churg A; Zhou S; Wright JL
Eur Respir J; 2012 Jan; 39(1):197-209. PubMed ID: 21920892
[TBL] [Abstract][Full Text] [Related]
28. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease.
Molet S; Belleguic C; Lena H; Germain N; Bertrand CP; Shapiro SD; Planquois JM; Delaval P; Lagente V
Inflamm Res; 2005 Jan; 54(1):31-6. PubMed ID: 15723202
[TBL] [Abstract][Full Text] [Related]
29. Airway dimensions in asthma and COPD in high resolution computed tomography: can we see the difference?
Kosciuch J; Krenke R; Gorska K; Zukowska M; Maskey-Warzechowska M; Chazan R
Respir Care; 2013 Aug; 58(8):1335-42. PubMed ID: 23307823
[TBL] [Abstract][Full Text] [Related]
30. Small Airway Disease in Pre-Chronic Obstructive Pulmonary Disease with Emphysema: A Cross-Sectional Study.
Verleden SE; Hendriks JMH; Snoeckx A; Mai C; Mentens Y; Callebaut W; De Belie B; Van Schil PE; Verplancke V; Janssens A; Jacob J; Pakzad A; Conlon TM; Guvenc G; Yildirim AÖ; Pauwels P; Koljenovic S; Kwakkel-Van Erp JM; Lapperre TS
Am J Respir Crit Care Med; 2024 Mar; 209(6):683-692. PubMed ID: 38055196
[No Abstract] [Full Text] [Related]
31. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
[TBL] [Abstract][Full Text] [Related]
33. Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD.
Kanazawa H; Tochino Y; Asai K; Ichimaru Y; Watanabe T; Hirata K
Eur J Clin Invest; 2012 Apr; 42(4):419-26. PubMed ID: 21950682
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy.
Suzuki R; Miyazaki Y; Takagi K; Torii K; Taniguchi H
Treat Respir Med; 2004; 3(1):17-27. PubMed ID: 15174890
[TBL] [Abstract][Full Text] [Related]
35. Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD.
Mohamed Hoesein FA; Schmidt M; Mets OM; Gietema HA; Lammers JW; Zanen P; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; Isgum I; Prokop M; van Ginneken B; van Rikxoort EM; de Jong PA
Respir Med; 2014 Jan; 108(1):136-43. PubMed ID: 24035313
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
37. Differences in regional air trapping in current smokers with normal spirometry.
Karimi R; Tornling G; Forsslund H; Mikko M; Wheelock ÅM; Nyrén S; Sköld CM
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122862
[TBL] [Abstract][Full Text] [Related]
38. [A study on pathological changes and the potential role of growth factors in the airway wall remodeling of COPD rat models].
Song Y; Cui D; Mao P
Zhonghua Jie He He Hu Xi Za Zhi; 2001 May; 24(5):283-7. PubMed ID: 11802977
[TBL] [Abstract][Full Text] [Related]
39. Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.
Navratilova Z; Kolek V; Petrek M
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):177-93. PubMed ID: 26611761
[TBL] [Abstract][Full Text] [Related]
40. Computed Tomography-based Subclassification of Chronic Obstructive Pulmonary Disease.
Dirksen A; Wille MM
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S114-7. PubMed ID: 27115944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
